Literature DB >> 32078816

Shortening HIV vaccine regimens to achieve high coverage.

Maria Blasi1, Genevieve G Fouda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32078816      PMCID： PMC7276282          DOI： 10.1016/S2352-3018(20)30039-4

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  8 in total

1.  Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).

Authors:  Kathryn E Stephenson; Frank Wegmann; Frank Tomaka; Stephen R Walsh; C Sabrina Tan; Ludo Lavreys; Jessica L Ansel; Diane G Kanjilal; Kate Jaegle; Joseph P Nkolola; Lauren Peter; Rachel Fogel; Connor Bradshaw; Anna Tyler; Tatenda Makoni; Lisa Howe; Darla Quijada; Abishek Chandrashekar; Esther A Bondzie; Erica N Borducchi; Katherine E Yanosick; Jenny Hendriks; Steven Nijs; Carla Truyers; Jeroen Tolboom; Roland C Zahn; Michael S Seaman; Galit Alter; Daniel J Stieh; Maria Grazia Pau; Hanneke Schuitemaker; Dan H Barouch
Journal:  Lancet HIV       Date:  2020-02-17       Impact factor: 12.767

Review 2.  Strengthening global vaccine access for adolescents and adults.

Authors:  Angeline Nanni; Stefanie Meredith; Stephanie Gati; Karin Holm; Tom Harmon; Ann Ginsberg
Journal:  Vaccine       Date:  2017-11-06       Impact factor: 3.641

Review 3.  Broadly Neutralizing Antibodies against HIV: Back to Blood.

Authors:  Amir Dashti; Anthony L DeVico; George K Lewis; Mohammad M Sajadi
Journal:  Trends Mol Med       Date:  2019-02-18       Impact factor: 11.951

4.  Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Authors:  Merlin L Robb; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Patricia Morgan; Michael Benenson; Robert M Paris; Joseph Chiu; Elizabeth Adams; Donald Francis; Sanjay Gurunathan; Jim Tartaglia; Peter Gilbert; Don Stablein; Nelson L Michael; Jerome H Kim
Journal:  Lancet Infect Dis       Date:  2012-05-30       Impact factor: 25.071

Review 5.  Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Authors:  Linda-Gail Bekker; George Alleyne; Stefan Baral; Javier Cepeda; Demetre Daskalakis; David Dowdy; Mark Dybul; Serge Eholie; Kene Esom; Geoff Garnett; Anna Grimsrud; James Hakim; Diane Havlir; Michael T Isbell; Leigh Johnson; Adeeba Kamarulzaman; Parastu Kasaie; Michel Kazatchkine; Nduku Kilonzo; Michael Klag; Marina Klein; Sharon R Lewin; Chewe Luo; Keletso Makofane; Natasha K Martin; Kenneth Mayer; Gregorio Millett; Ntobeko Ntusi; Loyce Pace; Carey Pike; Peter Piot; Anton Pozniak; Thomas C Quinn; Jurgen Rockstroh; Jirair Ratevosian; Owen Ryan; Serra Sippel; Bruno Spire; Agnes Soucat; Ann Starrs; Steffanie A Strathdee; Nicholas Thomson; Stefano Vella; Mauro Schechter; Peter Vickerman; Brian Weir; Chris Beyrer
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

6.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

7.  Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Authors:  Dan H Barouch; Frank L Tomaka; Frank Wegmann; Daniel J Stieh; Galit Alter; Merlin L Robb; Nelson L Michael; Lauren Peter; Joseph P Nkolola; Erica N Borducchi; Abishek Chandrashekar; David Jetton; Kathryn E Stephenson; Wenjun Li; Bette Korber; Georgia D Tomaras; David C Montefiori; Glenda Gray; Nicole Frahm; M Juliana McElrath; Lindsey Baden; Jennifer Johnson; Julia Hutter; Edith Swann; Etienne Karita; Hannah Kibuuka; Juliet Mpendo; Nigel Garrett; Kathy Mngadi; Kundai Chinyenze; Frances Priddy; Erica Lazarus; Fatima Laher; Sorachai Nitayapan; Punnee Pitisuttithum; Stephan Bart; Thomas Campbell; Robert Feldman; Gregg Lucksinger; Caroline Borremans; Katleen Callewaert; Raphaele Roten; Jerald Sadoff; Lorenz Scheppler; Mo Weijtens; Karin Feddes-de Boer; Daniëlle van Manen; Jessica Vreugdenhil; Roland Zahn; Ludo Lavreys; Steven Nijs; Jeroen Tolboom; Jenny Hendriks; Zelda Euler; Maria G Pau; Hanneke Schuitemaker
Journal:  Lancet       Date:  2018-07-06       Impact factor: 79.321

8.  Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries.

Authors:  Thomas M Harmon; Kevin A Fisher; Margaret G McGlynn; John Stover; Mitchell J Warren; Yu Teng; Arne Näveke
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240
  8 in total
  1 in total

1.  Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs.

Authors:  Maria Blasi; Donatella Negri; Kevin O Saunders; Erich J Baker; Hannah Stadtler; Celia LaBranche; Benjamin Mildenberg; Georgeanna Morton; Andrew Ciarla; Xiaoying Shen; Yunfei Wang; Wes Rountree; Bala Balakumaran; Sampa Santra; Barton F Haynes; Anthony M Moody; Andrea Cara; Mary E Klotman
Journal:  NPJ Vaccines       Date:  2020-11-18       Impact factor: 7.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.